dapagliflozin 5 MG / metformin hydrochloride 1000 MG [Xigduo]
- RxCUI
- 1593828
- RxNorm name
- dapagliflozin 5 MG / metformin hydrochloride 1000 MG [Xigduo]
- Term type
- SBDC
- Status
- Active
- Updated
- 2026-10-15 14:50:20
RxNorm Status History#
- Status
- Active
- Source
- RXNORM
- Current
- YES
- Release start
- 122014
- Active start
- 122014
- Multiple ingredient
- YES
- Branded
- YES
Ingredients And Strength#
| Ingredient | Strength | Base | Basis of strength |
|---|---|---|---|
| 5 MG / 1 EACH | dapagliflozin | ||
| 1000 MG / 1 EACH | metformin |
Derived Ingredient Concepts#
| Ingredient | RxCUI |
|---|---|
| dapagliflozin | 1488564 |
| metformin | 6809 |
Source Vocabulary Codes#
| Code type | Values | Count | Category |
|---|---|---|---|
| PRESCRIBABLE | Y | 1 | ATTRIBUTES |
| RXNAV_STR | dapagliflozin 5 MG / metFORMIN hydrochloride 1000 MG [Xigduo] | 1 | NAMES |
| RxNorm Name | dapagliflozin 5 MG / metformin hydrochloride 1000 MG [Xigduo] | 1 | NAMES |
| TTY | SBDC | 1 | ATTRIBUTES |
| RxCUI | 1593828 | 1 | CODES |
UNII Substances#
No records found.
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed RxNorm Mappings#
No records found.
Drug Classes#
| Source | Class ID | Class | Type | Relationship | Drug concept |
|---|---|---|---|---|---|
| ATC | A10BA | Biguanides | ATC1-4 | metformin | |
| ATC | A10BD | Combinations of oral blood glucose lowering drugs | ATC1-4 | dapagliflozin / metformin | |
| ATC | A10BK | Sodium-glucose co-transporter 2 (SGLT2) inhibitors | ATC1-4 | dapagliflozin | |
| FDASPL | D001645 | Biguanides | CHEM | has_chemical_structure | metformin |
| FDASPL | N0000175565 | Biguanide | EPC | has_epc | metformin |
| FDASPL | N0000187059 | Sodium-Glucose Cotransporter 2 Inhibitor | EPC | has_epc | dapagliflozin |
| FDASPL | N0000187058 | Sodium-Glucose Transporter 2 Inhibitors | MOA | has_moa | dapagliflozin |
| MEDRT | D001559 | Benzhydryl Compounds | CHEM | has_ingredient | dapagliflozin |
| MEDRT | D005960 | Glucosides | CHEM | has_ingredient | dapagliflozin |
| MEDRT | D008687 | Metformin | CHEM | has_ingredient | metformin |
| MEDRT | D008687 | Metformin | CHEM | has_ingredient | metformin hydrochloride |
| MEDRT | D000138 | Acidosis | DISEASE | ci_with | metformin hydrochloride |
| MEDRT | D000138 | Acidosis | DISEASE | ci_with | metformin |
| MEDRT | D003924 | Diabetes Mellitus, Type 2 | DISEASE | may_treat | metformin |
| MEDRT | D003924 | Diabetes Mellitus, Type 2 | DISEASE | may_treat | dapagliflozin |
| MEDRT | D003924 | Diabetes Mellitus, Type 2 | DISEASE | may_treat | metformin hydrochloride |
| MEDRT | D016883 | Diabetic Ketoacidosis | DISEASE | ci_with | metformin |
| MEDRT | D016883 | Diabetic Ketoacidosis | DISEASE | ci_with | metformin hydrochloride |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | metformin hydrochloride |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | metformin |
| MEDRT | D006333 | Heart Failure | DISEASE | may_treat | dapagliflozin |
| MEDRT | D008107 | Liver Diseases | DISEASE | ci_with | metformin hydrochloride |
| MEDRT | D008107 | Liver Diseases | DISEASE | ci_with | metformin |
| MEDRT | D051437 | Renal Insufficiency | DISEASE | ci_with | metformin hydrochloride |
| MEDRT | D051437 | Renal Insufficiency | DISEASE | ci_with | metformin |
| MEDRT | N0000000225 | Insulin Receptor Agonists | MOA | has_moa | metformin |
| MEDRT | N0000000225 | Insulin Receptor Agonists | MOA | has_moa | metformin hydrochloride |
| MEDRT | N0000187058 | Sodium-Glucose Transporter 2 Inhibitors | MOA | has_moa | dapagliflozin |
| MEDRT | N0000008646 | Decreased Gluconeogenesis | PE | has_pe | metformin hydrochloride |
| MEDRT | N0000008646 | Decreased Gluconeogenesis | PE | has_pe | metformin |
| MEDRT | N0000008650 | Decreased Glycogenesis | PE | has_pe | metformin |
| MEDRT | N0000008650 | Decreased Glycogenesis | PE | has_pe | metformin hydrochloride |
| MEDRT | N0000175650 | Decreased Sympathetic Activity | PE | has_pe | dapagliflozin |
| MEDRT | N0000009341 | Increased Glucose Transport into Cells | PE | has_pe | metformin hydrochloride |
| MEDRT | N0000009341 | Increased Glucose Transport into Cells | PE | has_pe | metformin |
| MEDRT | N0000009556 | Increased Renal Organic Ion Excretion | PE | has_pe | dapagliflozin |
| MEDRT | N0000009830 | Renal Ion Transport Alteration | PE | has_pe | dapagliflozin |
| MEDRT | N0000000042 | Renal Excretion | PK | has_pk | metformin |
| MEDRT | N0000000042 | Renal Excretion | PK | has_pk | metformin hydrochloride |
Properties#
| Category | Property | Value |
|---|---|---|
| ATTRIBUTES | GENERAL_CARDINALITY | MULTI |
| ATTRIBUTES | RXNAV_HUMAN_DRUG | US |
| NAMES | Tallman Synonym | dapagliflozin 5 MG / metFORMIN hydrochloride 1000 MG [Xigduo] |